Product Program year 2025 Source: CMS Open Payments

Stellaris

Device Ophthalmology

PDI 00757770497836

Open in the dashboard

General payments

$725,161

4,276 payments

Research payments

$96,250

1 payment

Through program year 2025, $725,161 in general payments and $96,250 in research payments were reported against Stellaris (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $290,279 1,277
2024 General $99,005 730
2023 General $79,265 735
2022 General $167,425 1,151
2022 Research $96,250 1
2021 General $89,186 383

Breakdown

Who paid General payments · program years 2021–2025
  1. Bausch & Lomb Americas Inc. $635,975 3,893 payments
  2. Bausch & Lomb, a division of Bausch Health US, LLC $89,186 383 payments
Top recipients General payments · program year 2025
  1. Prethy Rao Ophthalmology · Bellaire, TX $24,669 8% · 22 payments
  2. Sunil Srivastava Ophthalmology · Cleveland, OH $20,900 7% · 13 payments
  3. Kevin Blinder Retina Specialist · Brentwood, MO $12,664 4% · 12 payments
  4. Mark Barakat Ophthalmology · Scottsdale, AZ $12,146 4% · 5 payments
  5. Justin Townsend Retina Specialist · Miami, FL $11,647 4% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $195,874 71% · 399 practitioners
  2. Retina Specialist Ophthalmology $70,652 26% · 82 practitioners
  3. Cornea and External Diseases Specialist Ophthalmology $3,194 1% · 15 practitioners
  4. Optometrist $1,434 <1% · 22 practitioners
  5. Nurse Anesthetist, Certified Registered $1,034 <1% · 35 practitioners

The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $44,697 15% · 43 recipients
  2. Pennsylvania $40,630 14% · 52 recipients
  3. Florida $27,831 10% · 79 recipients
  4. Ohio $27,515 9% · 34 recipients
  5. Missouri $20,600 7% · 49 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,276 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record